Sensex gains for fifth day straight; NSE up by 0.25%
Indian shares edged higher on Monday, heading for a fifth straight session of gains after earnings of blue chips such as Hindalco Industries Ltd beat street estimates, boosting hopes that the economy was recovering.
The broader NSE Nifty was up 0.25 % at 8177.3 as of 0809 GMT, after gaining 5.6 % over the previous four sessions.
The benchmark BSE Sensex was 0.27 % higher at 26730.82.
Earnings for the January-March quarter have so far been largely better than street estimates, raising optimism over India`s economic prospects, with investors betting that above-average monsoon rainfalls would support rural demand.
However, traders say the current rally could be speculative as foreign investors have been buying very little in cash and that most of their buying has been in index futures and options.
Traders also warned that the gains could be capped by global developments, including the prospect of a U.S. rate hike, even as foreign investors bought a net 103.3 billion rupees ($1.54 billion) in index futures and options over the past two sessions.
Hemen Kapadia, senior vice president at KR Choksey Securities, said he was surprised at the buying by foreign investors but added that he still expected a correction to follow the gains.
"We have to respect the prices and we think 8300-8350 could be seen with a small correction, which is overdue after this stellar rally," he said.
"Going ahead, U.S. Federal Reserve meeting and Brexit are the key triggers to watch, which will keep upside capped."
Hindalco Industries shares surged 12 % after the company said its net profit more than doubled in the January-March quarter, surprising analysts and beating estimates.
Shares of state-run State Bank of India gained 2 % after India`s biggest lender on Friday reported quarterly earnings that were worse than expected but said fewer than feared of its loans risked turning sour.
Among decliners, shares of Sun Pharmaceutical Industries fell 1 pct after the U.S. Department of Justice subpoenaed India`s largest drugmaker over the pricing and marketing of generic drugs it sells in the United States, as part of a broader investigation.
($1 = 67.2800 Indian rupees)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
03:53 PM IST